Endometrial Carcinoma

Parkash V, Vinita Parkash, Fadare O, Oluwole Fadare
Surgical pathology clinics · 2019 · vol. 12(2) , pp. 329–342 · doi:10.1016/j.path.2019.02.002 · PMID:31097107 · W2986031136
review OA: closed CC0
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper describes the pathology and clinical features of endometrial carcinoma.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

This article gives an overview of the pathologic assessment of resection specimens removed for uterine carcinoma. Areas of controversy and recent developments in pathologic staging are addressed. This includes assessment of myometrial invasion in the setting of adenomyosis, fallopian tube involvement, and vascular invasion. An overview of the role and evaluation of sentinel node assessments in the staging of endometrial carcinoma is provided.

My notes (saved in your browser only)

MeSH descriptors

Endometrial Neoplasms Sentinel Lymph Node Biopsy Blood Vessels Blood Vessels Endometrial Neoplasms Endometrial Neoplasms Fallopian Tubes Fallopian Tubes Female Frozen Sections Humans Hysterectomy Lymphatic Metastasis Neoplasm Invasiveness Neoplasm Staging Sentinel Lymph Node Sentinel Lymph Node Biopsy Specimen Handling Specimen Handling

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (36)

Source provenance

europepmc
last seen: 2026-08-05T06:13:34.187606+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:22:48.502547+00:00
License: CC0 · commercial use OK